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Social scientists can adopt many different roles and responsibilities when they study scientific 
research: they can be advocates, intermediaries, translators, connoisseurs, critics, activists, or 
reformers. They can reflect on the implications of a finished piece of research, or become 
involved at a much earlier stage. In newly emerging areas of scientific research, we are seeing 
novel arrangements forming among natural and social scientists, whereby social scientists are 
becoming a required component of research programmes, and are even involved in the 
creation of new fields. Our aim here is to explore these developments and examine the 
different possible roles that social scientists may play in debates about new technologies by 
using the example of synthetic biology. 
 
Synthetic biology is a ‘field in the making’ that combines the expertise and knowledge of 
biologists and engineers. It is accompanied by both high expectations and considerable 
uncertainty; there are major debates about its definition, its potential applications, safety 
considerations and how it should be institutionalised. In common with other emerging areas 
of technology and science, synthetic biology covers a broad and disparate set of research 
activities, and there is as yet no consensus on how the field should be defined; although the 
most common definitions of synthetic biology emphasise both the building of new biological 
entities and the improvement of existing ones. A group at the Massachusetts Institute of 
Technology (MIT: Cambridge, MA, USA), for example, defines synthetic biology as “the 
design and construction of new biological parts, devices, and systems and the re-design of 
existing, natural biological systems for useful purposes” (www.syntheticbiology.org).  
 
In practice, many different activities are pursued under the heading of synthetic biology 
(O’Malley et al., 2008), including the construction of interchangeable biological parts and 
devices—often called BioBricksTM—the generation and modification of whole genomes, 
including the synthesis of viral genomes from scratch and the reduction of existing bacterial 
genomes, and attempts to create ‘protocells’ from simple components. Given the range of 
work that describes itself as ‘synthetic biology’, it is hard to strictly delimit the field at 
present.  
 
Many synthetic biologists aspire to make biology into an engineering discipline. By explicitly 
adopting engineering principles, such as standardisation, decoupling and abstraction, these 
synthetic biologists distinguish their work from previous genetic engineering (Endy, 2005). 
The possible practical applications of synthetic biology include the production of biofuels, 
new tools for bioremediation, biosensors, in vivo health applications, new drug development 
pathways, synthetic vaccines and biobased manufacturing (ITI Life Sciences, 2007). Most 
notably, synthetic biologists have already generated a genetically modified bacterium that 
produces a precursor for the antimalarial drug artemisinin (Ro et al., 2006).  
 
Although synthetic biologists distinguish their work from genetic engineering, it is undeniable 
that this new field gives rise to similar fears, which means that there is already an established 
set of anxieties to which synthetic biology relates. Both genetic engineering and synthetic 
biology involve the modification of living organisms, which, by definition, are self-
 2
propagating. But synthetic biology adds a new dimension because the development of the 
internet and the routinisation of many biotechnological procedures have made the field more 
easily accessible (Garfinkel et al., 2007). For instance, MIT organizes an undergraduate 
competition each year where students ‘programme’ bacteria to perform certain functions 
(www.igem.org). In this way, we see the potential ‘domestication’ or ‘deskilling’ of 
biotechnology, which is leading to concerns about ‘garage biology’ and ‘biohackers’. 
 
However, many of these concerns are rather anticipatory. Most of the current work in 
synthetic biology is funded by public institutions rather than large companies; an indication 
that much of it is still far from being suitable for commercial exploitation or routine 
application (De Vriend, 2006). Perhaps all that we can be sure of is that the rapidly increasing 
speed and the equally decreasing cost of DNA synthesis will accelerate the progress of 
experimental research in the biological sciences (Endy, 2005). 
 
Although there is no consensus on the definition of synthetic biology, there is a widespread 
conviction that it has important ethical, legal and social implications (ELSI), and that these 
should be explicitly addressed. Most reports about the field rehearse a standard list of these 
implications of synthetic biology, which include concerns about biosafety, biosecurity, 
intellectual property and the status of ‘nature’.  
 
What is particularly interesting about this new field is the fact that the scientific community is 
aware that their research has the potential to be extremely contentious, and many scientists 
regularly write about and publicly discuss regulatory, social and ethical issues. For example, 
at the Second International Conference on Synthetic Biology in 2006 in Berkeley, CA, USA, 
the participants put forward a declaration on governance of the field, which focused on 
biosecurity issues and emphasized self-regulation. However, this met with negative responses 
from a global coalition of civil society organizations, who wrote an open letter stating that 
“we believe that this potentially powerful technology is being developed without proper 
societal debate concerning socio-economic, security, health, environmental and human rights 
implications” and emphasised the necessity for broad and inclusive public debate (ETC 
Group, 2006).  
 
One response to such concerns about synthetic biology has been to institutionalise the 
involvement of social scientists in the field. There have been a series of initiatives in which 
ELSI activities have become purposely incorporated into synthetic biology discussion and 
research. In the UK, four research councils have funded seven scientific networks in synthetic 
biology that require an ELSI component. The Biotechnology and Biological Sciences 
Research Council (BBSRC; Swindon, UK) explains this decision by stating that “[i]t is very 
important that ethical and other social issues are identified at this early stage in the 
development of Synthetic Biology, before new products and processes are made, so that 
research funders and researchers can take these into consideration” (BBSRC, 2008).  
 
Similarly, the European Commission’s Seventh Framework Programme funds a project called 
SYNBIOSAFE, which “aims to proactively stimulate a debate on these issues” 
(http://www.synbiosafe.eu/). The introduction on the project’s website states that “[i]n order 
to ensure a vital and successful development of this new scientific field—in addition to 
describ[ing] the potential benefits—it is absolutely necessary to gather information also about 
the risks and to devise possible biosafety strategies to minimize them”. The overall goal of 
SYBNIOSAFE is to create “the framework within which Europe’s fledgling synthetic biology 
industry can flourish”. In particular, SYBNIOSAFE cites the ongoing debate about GM crops 
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as an example of how this has failed in the past: “Past experiences, especially in the field of 
GM-crops, have shown the importance of an early bio-safety and ethics debate.” 
 
The USA has also incorporated ELSI activities into synthetic biology projects. The Synthetic 
Biology Engineering Research Center (SynBERC; Berkeley, CA, USA), funded by the US 
National Science Foundation (NSF; Arlington, VA, USA), has involved collaborations 
between the natural and human sciences from the outset. Unlike Europe, the USA has seen no 
bitter and divisive debate about GM crops. Instead, the ELSI component of SynBERC seems 
to mirror a similar ELSI component of nanotechnology (see for example http://cns.asu.edu/).  
 
These examples are just a selection of the initiatives where funding agencies are ensuring that 
consideration of ELSIs relating to synthetic biology are integral to the development of the 
scientific research. This generates various questions for social scientists: why is this 
happening? Why are social scientists being invited to join the natural scientists? What role are 
they expected to play? When these questions are asked in a European context, the most 
common answer is that scientists and policy makers want to avoid another failed GM crop 
debate. Those who provide the funding for synthetic biology hope that by involving social 
scientists, ethicists and philosophers at an early stage, they will prevent such a failure from 
happening again. 
 
Given the increasing involvement of researchers from the social sciences in synthetic biology, 
we are left with the question of how these social scientists should become involved. Here we 
put forward two contrasting ways of imagining a social scientist’s role in a synthetic biology 
research programme:  a ‘contributor’ and a ‘collaborator’.  
 
A ‘contributor’ is a social scientist, who, as the name implies, contributes to and facilitates the 
progress of the field. A contributor can be easily ‘plugged in’ to ongoing debates to cover the 
ethical, legal and social implications of research. The involvement of a contributor is often 
accompanied by the assumption that those who study the ‘social’ dimensions of a scientific 
field also have the competence needed to cover the social, legal, regulatory, philosophical and 
ethical perspectives; the inclusion of such a ‘jack-of-all-trades’ thus means that input from 
other experts is not required. In fact, ‘ethicist’ is sometimes used as a catch-all term for those 
who study new technologies and who are not scientists or engineers.  
 
A ‘contributor’ studies the effects or consequences of scientific research. Indeed, ELSI stands 
for Ethical, Legal and Social Implications, which implies that once the natural scientists have 
done their work, the social scientists arrive to explore the implications of this work for 
society, perhaps by drawing analogies with similar technological developments in the past. 
The hope is that an early prediction of the possible negative implications of new technologies 
may help to prevent them. 
 
Another way of ‘contributing’ to synthetic biology is to represent the ‘public’. At one UK 
synthetic biology conference, social scientists were labelled as “members of society” in the 
programme. Obviously, the organizers assumed that the social scientists represented society 
more than the scientists and engineers at the conference, and thought perhaps that their 
presence democratised the proceedings. 
 
Similar attitudes towards social scientists are found in the nanotechnology field; McNaughten 
et al. (2005) argue that this relies on “[t]he appeal to social scientists as experts in the study of 
public opinion and political mobilization processes” with the aspiration that “such socially 
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sensitive intelligence may help avoid future disruptive public controversy.” Although it may 
not be accurate to label social scientists as representatives of the public in this way, it 
demonstrates recognition of a ‘public’ voice that needs to be taken into account. 
 
Another imagined role for the social scientist is to be a ‘broker’, ‘translator’ or ‘facilitator’ 
between different groups of actors, particularly scientists and publics. Social scientists have 
played this role in the nanotech debate where their knowledge of the field has allowed them to 
“better elaborate assessment of societal impacts and interact with publics accordingly” 
(Barden et al., 2008). The idea here is that the social scientist can transmit scientific 
knowledge to the public, and, vice versa, knowledge about public attitudes to the scientists 
and policy makers. 
 
The role of ‘contributor’ is not the only one that social scientists can play in new scientific 
fields, however. An alternative view sees them as ‘collaborators’, which we define as 
involvement that can potentially influence the scientific knowledge that is produced. For a 
collaborator, the demand for social scientific input into debates about synthetic biology is a 
unique opportunity. The UK’s research councils require an ELSI component in network 
proposals in synthetic biology, and, although this could end up as a token contribution, it 
could also become a more genuinely collaborative exercise. There is an opportunity for 
authentically interdisciplinary work to take place that does not just follow the scientific 
research, but interacts with it. This is made more likely because social scientists are being 
involved in synthetic biology at the ‘upstream’ end, when the research is in its early stages.  
 
Much of the literature that discusses disruptive technologies, such as GM crops and 
nanotechnology, suggests that the role of the social scientist in these situations should be to 
explore the normative assumptions that lie behind the choices that are made, or to engage in 
‘opening up’, as Stirling (2005) puts it, which involves asking broader questions that go 
beyond the specific technology under scrutiny, such as questions about the aims of scientific 
research, and what is meant by ‘good science’ (Wilsdon et al., 2005). This is far from merely 
reflecting on the ‘implications’ of a technology on society. 
 
Other commentators talk about the importance of making scientists “more self-aware of their 
own taken-for-granted expectations, visions, and imaginations of the ultimate ends of 
knowledge” (MacNaughten et al., 2005). The objective of such processes is to create ‘citizen 
scientists’ who become “sensitised through engagement to wider social imaginations” 
(Wilsdon et al., 2005), and who reflect on the social and ethical dimensions of their work. We 
think that this attempt to examine one’s own assumptions—sometimes called ‘reflexivity’—
can go beyond facilitating social and ethical reflection amongst natural scientists and 
engineers, however. Discussions about implicit assumptions could potentially enable both 
scientists and social scientists to imagine their work differently, in ways that are not habitual 
and familiar. This ‘reciprocal reflexivity’ could contribute to a new set of expectations about 
the research.  
 
There are positive indications that such attempts to engage in reciprocal reflexivity may work. 
The synthetic biology community is remarkably open to collaboration with people from 
outside the field, and keen to initiate discussions of their work. In our involvement in 
synthetic biology, we have already come across some possibilities for genuine collaboration.  
 
Synthetic biology is therefore a fascinating field not only for biologists and engineers, but 
also for social scientists, because the anticipation of its ethical, legal and social implications is 
 5
becoming institutionalised. It is thus important for social scientists to define their role more 
proactively in these emerging configurations, because the role they imagine for themselves 
and the role that other groups imagine for them may differ. We should also be aware that 
there have been similar discussions in other emerging scientific fields, and that much can be 
learnt from work on other potentially disruptive new technologies.  
 
As we have shown, the role of a social scientist in synthetic biology can be defined either as a 
contributor—an easily plugged-in ELSI expert, who enters the scene after the scientific 
knowledge has been produced—or as a collaborator. As a contributor, they may represent the 
public, or become a translator between the natural scientists and the public. But we would 
argue that the role of a collaborator—as an alternative way to understand social scientific 
involvement in synthetic biology—is preferable, as it represents a genuine opportunity for 
truly collaborative work. This could involve scrutinising the assumptions underlying the 
research of both natural and social scientists, and challenging habitual ways of thinking 
among both groups. Perhaps the involvement of social scientists in synthetic biology could 
lead to the development of a new form of reciprocally reflexive science that brings about 
novel forms of collaboration, learns from previous problems, and helps to create a more 
ethically acceptable and socially useful field of study and application. 
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